Table: begin end state 1 27 cytoplasmic 28 50 transmembrane 51 64 non-cytoplasmic 65 87 transmembrane 88 93 cytoplasmic 94 114 transmembrane 115 119 non-cytoplasmic 120 145 transmembrane 146 164 cytoplasmic 165 185 transmembrane 186 210 non-cytoplasmic 211 230 transmembrane 231 256 cytoplasmic 257 279 transmembrane 280 298 non-cytoplasmic 299 318 transmembrane 319 324 cytoplasmic 325 342 transmembrane 343 347 non-cytoplasmic 348 371 transmembrane 372 382 cytoplasmic 383 402 transmembrane 403 407 non-cytoplasmic 408 428 transmembrane 429 442 cytoplasmic
Input: >N515DRAFT_1918 MAFAAPPAPSKTSLPGAARERYTDYPMAMGVLTSIFFMWGFLTCLNDILIPHLKAVFKLN YAEAMLVQFTFFGAYFLMSLPAGLLVARLGYKKGIVAGLAVAGVGAAGFWPAAAMHFYPA FLGALFVLATGITVLQVAANAYVALLGPEKSASSRLTLAQALNSLGTFLAPKFGGLLILS AAVLSAEQIAKLSPAEQVAYRVQEAQTVQGPYLGLAIVLFLLAVFVYLFRLPALTEKTEQ ASVKQHSLVSPLRHPHVLFGVLAIFFYVGGEVAIGSFLVNYLSMPDIGNMSEQAAANWVA YYWLGAMIGRFIGSALLAKLSPRKLLAIFAAINMALVLTTMMTKGTVAMYSVVSIGLFNS IMFPTIFSLGIERMGPMTGEASSLLIMAIVGGAIVPFVQGLFADHIGVQHAFFLPLLCYA YIVFYGLYGSRIKSDTPVAATH
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server